Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

AHA Journal Confirms Heart Laser Results

Facebook Twitter LinkedIn Email Comments
FRANKLIN, Mass., Sept. 19 -- Cardiac patients who have received carbon dioxide (CO2) transmyocardial revascularization (TMR) using PLC Systems' heart laser are experiencing excellent long-term clinical benefits said a report published in Circulation, the official journal of the American Heart Association. The angina relief benefits are sustained for five years and beyond after the revascularization therapy. The report was based on data from a multicenter, long-term study on the efficacy of CO2 revascularization.

"Angina relief from CO2 revascularization continues for five years and beyond," said Dr. Keith Horvath, lead author of the study and assistant professor of surgery at Northwestern University Medical Center. "The CO2 heart laser is the only TMR laser to demonstrate effective, sustained, long-term angina relief to severely debilitated heart patients. Additional studies have demonstrated that the CO2 revascularization therapy promotes an angiogenic response, which is the foundation for the long-term clinical benefits. These results are directly attributable to the favorable interaction between the CO2 laser and the tissue of the heart."
Sep 2001
CO2 lasersNews & Featureslasers

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.